July 5, 2017 / 8:10 AM / a month ago

BRIEF-Alexion reaches funding agreement with NICE and NHS England for Strensiq

July 5 (Reuters) - Alexion Pharmaceuticals Inc

* Says has reached national funding agreement with NICE & NHS England based on Managed Access Agreement

* Says Managed Access Agreement provides access to Strensiq for patients in England with Pediatric-onset Hypophosphatasia, regardless of current age Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below